Title : The future is now for precision genomiaddiction medicine as a frontline modality for inducing dopamine homeostasis in reward deficiency syndrome
Abstract:
In this genomic era of addiction medicine, ideal treatment planning begins with genetic screening to determine neurogenetic antecedents of Reward Deficiency Syndrome (RDS) phenotype. Patients suffering from endotype addictions and mental disorders share the common underlying neurobiology of dopamine dysfunction.
Audience Take Away:
- The audience will learn about the advancements in molecular biology which have changed the addiction recovery landscape.
- The audience will learn how to distinguish genetics from genomics, and be taught why these are important to addiction medicine, behavioral health and psychology.
- Practitioners will receive a brief introduction to Reward Deficiency Syndrome psychoeducation, which is continuing education in genomic medicine.
- Case study research of the effectiveness of Precision Genomic Addiction Medicine, as compared to traditional treatment is well received.
Biography:
Elizabeth Dale Gilley earned a corporate paralegal degree in 1979, a Bachelor of Science in Business Administration, from Wake Forest University in 1983. She earned a Masters in General Psychology in 2017 and a Post Masters Certificate with a specialty in addictions, in 2019, from NorthCentral University. She is currently PhD candidate in Psychology at National University. Her research focus in on screening for genetic and neurobiological biomarkers of mental disorder.
She created Reward Deficiency Syndrome Psychoeducation therapy, the RDS treatment plan model, RDS Solution Focused Brief Intervention therapy, and the RDS Severity of Symptom scale, to facilitate integrating precision genomic medicine into the traditional treatment industry. She has published in peer review consistently since 2017. She is a frequent keynote and/or scientific committee member for global conferences.
In 1995, she incorporated the Elle Foundation, a private nonprofit to help stop the cycle of addiction. She recently opened two divisions: Elle Research and Elle Resource.
